$AURA
Aura Biosciences, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Boston, MA
AURA chart
What traders are saying about $AURA
Latest postsAura Biosciences, Inc. news
- Aura Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
marketscreener.com ·
- Aura Biosciences Posts $32.1M Q3 Loss, Completes CoMpass Treatment, Cash Into 1H 2029
Minichart ·
- Aura Biosciences Reports Q3 2026 Loss of $32.1 Million and GAAP EPS of -$0.29, Exceeding Estimates
GuruFocus ·
- Aura Biosciences Reports Third-Quarter Results and Clinical Progress
TipRanks ·
- AURA: SEC Form 10-Q filed by Aura Biosciences Inc.
Quantisnow ·
- Aura Biosciences, Inc. (AURA) Tops Q3 EPS by 8c
StreetInsider ·
- A $32.1M quarterly loss accompanies workforce cuts at Aura Biosciences (AURA).
Stock Titan ·
- Form 8K Aura Biosciences Inc For: 9 November By Investing.com
Investing.com UK ·
- Aura Biosciences Q3 net loss widens on higher R&D and restructuring costs
TradingView ·
- Aura Biosciences Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Yahoo Finance ·
- Aura Biosciences, Inc. (AURA) Seasonal returns chart - Yahoo Finance
Yahoo Finance Singapore ·
- Aura Biosciences CEO to present at Stifel 2026 Healthcare Conference on novel ocular cancer therapy
Pluang ·
Aura Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$106.2M | -$86.9M | -$76.4M | -$58.8M |
| Diluted EPS | $-1.76 | $-1.75 | $-1.93 | $-1.96 |
| Total assets (year end) | $169.4M | $182.5M | $255.1M | $223.9M |
| Cash and equivalents (year end) | $59.5M | $31.7M | $41.1M | $121.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Aura Biosciences, Inc.
- Ticker
- AURA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1501796
Frequently asked questions
What exchange is Aura Biosciences, Inc. listed on?
Aura Biosciences, Inc. trades on the Nasdaq under the ticker symbol AURA.
What industry is Aura Biosciences, Inc. in?
Aura Biosciences, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Aura Biosciences, Inc. headquartered?
Aura Biosciences, Inc.'s business address on file with the SEC is in Boston, MA.
When does Aura Biosciences, Inc.'s fiscal year end?
Aura Biosciences, Inc.'s fiscal year ends on December 31.